Literature DB >> 6819908

Differentiation of benign monoclonal gammopathy and smouldering multiple myeloma from frank myeloma.

K Shimizu, K Ohnishi, A Kunii.   

Abstract

Circulating immunoglobulin (Ig) secreting cells of each type of the different Ig classes were enumerated using a reverse haemolytic plaque assay in nine subjects with the pre-clinical phase of IgG myeloma (six with benign monoclonal gammopathy and three with smouldering multiple myeloma). A shift in the ratio of IgG kappa to IgG lambda secreting cells without a significant increase in the total number of IgG secreting cells, that is the number of IgG kappa plus IgG lambda secreting cells, was a constant feature noted in every subject.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6819908      PMCID: PMC1536817     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  8 in total

1.  Multiple myeloma or benign monoclonal gammopathy? A study of differential diagnostic criteria in 44 cases.

Authors:  F D Lindström; U Dahlström
Journal:  Clin Immunol Immunopathol       Date:  1978-06

2.  A plaque assay to enumerate circulating Ig-secreting cells of each type of the different Ig classes.

Authors:  K Shimizu; A Hirano; A Kunii
Journal:  Blood       Date:  1980-08       Impact factor: 22.113

3.  Smoldering multiple myeloma.

Authors:  R A Kyle; P R Greipp
Journal:  N Engl J Med       Date:  1980-06-12       Impact factor: 91.245

4.  Clinical classification of plasma cell myeloma.

Authors:  R Conklin; R Alexanian
Journal:  Arch Intern Med       Date:  1975-01

5.  Monitoring myelomatosis.

Authors:  J R Hobbs
Journal:  Arch Intern Med       Date:  1975-01

6.  Management and prognosis of multiple myeloma.

Authors:  R A Kyle; L R Elveback
Journal:  Mayo Clin Proc       Date:  1976-12       Impact factor: 7.616

7.  Circulating immunoglobulin-secreting cells in patients with plasma cell dyscrasia.

Authors:  K Shimizu; T Murate; A Kunii
Journal:  Blood       Date:  1980-04       Impact factor: 22.113

8.  Three cases of multiple myeloma in which the preclinical asymptomatic phases persisted throughout 15 to 24 years.

Authors:  O Norgaard
Journal:  Br J Cancer       Date:  1971-09       Impact factor: 7.640

  8 in total
  6 in total

1.  Antigen stimulated IgM secretion by circulating B lymphocytes in patients with benign and malignant IgG gammopathy. Relationship to stage of disease.

Authors:  S Pollack; R Katz; I Tatarsky; A Carter
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

2.  Differentiation of plasma cell infiltrates in the bone marrow. A clinicopathological study on 80 patients including immunohistochemistry and morphometry.

Authors:  J Thiele; B Arenz; H Klein; M Vierbuchen; R Zankovich; R Fischer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

3.  Lymphocyte subsets in the peripheral blood of patients with multiple myeloma and benign monoclonal gammopathy.

Authors:  F Herrmann; A Lochner; B Jauer; G Sieber; H Rühl
Journal:  Klin Wochenschr       Date:  1983-08-15

4.  Detection and identification of serum monoclonal immunoglobulin by immunoisoelectric focusing. Limits of sensitivity and use during relapse of multiple myeloma.

Authors:  D Sinclair; D S Kumararatne; D Stott
Journal:  J Clin Pathol       Date:  1984-03       Impact factor: 3.411

5.  Immunoglobulin secretion by peripheral blood and bone marrow B cells in patients with multiple myeloma. Studies by the reverse haemolytic plaque assay.

Authors:  F Dammacco; A Vacca; E Altomare; N Campobasso
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

6.  Bone-marrow plasmocytosis--an immunohistological study.

Authors:  F Eckert; L Schmid; D Kradolfer; U Schmid
Journal:  Blut       Date:  1986-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.